The constitution of a biological samples bank, attached to epidemiological studies Cohort F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic variants that can modulate the iatrogenic risks of these treatments. The main objective is to provide a biological samples bank to consider, besides the carcinogenic risks, the risk of other iatrogenic diseases in these children, in particular cardiac, cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and in some cases, fatal. Their impact, however, is poorly estimated as occurring in adulthood, they are rarely made in relation to the treatment received in childhood. The overall project is expected to eventually better define the iatrogenic effects prevention strategies for cancer treatment.
Patients treated for a first cancer in childhood
Adult patients
Signed informed consent
Patient insured or enjoying a social security scheme
Minor patients
Under legal protection measure patients
Refusal of consent
Patients treated for a paediatric malignancies before the year 2000 having survived two years after treatment of solid tumor diagnosed before 18 years old
Cohort
Prospective
saliva samples
Procedure/Surgeryblood samples
Procedure/SurgeryStudy of genetic factors who might lead to secondary iatrogenic pathology due to treatment of a childhood cancer
Click on the lead sponsor to view all of their trials.
